ANTIMICROBIAL EFFECT OF CITRATE BUFFER WITH ANTIBIOTIC

Keywords: pathogens, endodontic infections, resistance, citrate buffer, antibiotics, sensitivity, minimal inhibitory concentration, minimal fungicidal concentration

Abstract

Antibiotic resistance of pathogens to medications is an essential problem globally. Thus, new medication compositions are one of the ways to solve this problem. This study aimed to investigate the antimicrobial efficacy of the citrate buffer combined with the antibiotic «Amoxiclav» on standard reference strains of microorganisms.

We used standard cultures of C. albicans ATCC10231, E. coli ATCC25922, S. aureus ATCC25923, E. faecalis ATCC29213, M. luteus ATCC4698, S. epidermidis ATCC14990 in the study conducted at the Microbiology, Virology and Immunology Department of the Poltava State Medical University. The sensitivity of standard microorganism strains to the composition was studied with a quantitative method of serial dilutions based on CLSI. ISO/TC 212 «Clinical laboratory testing and in vitro diagnostic test systems. 2021».

Thus, the results of this study clearly showed a synergistic effect of citrate buffer and amoxiclav on all the reference strains of microorganisms. Reference strains of Staphylococcus aureus and epidermal staphylococcus showed the highest sensitivity to citrate buffer, which was 4 times (p < 0.05) higher than that shown by micrococci, enterococci and fungi, and 8 times (p < 0.01) higher than that of Escherichia coli, which appeared least sensitive to the test substance. Amoxiclav also inhibited the growth of S. aureus ATCC 25923 and S. epidermidis ATCC 14990 and had the minimal effect on the reference strain of E. coli ATCC 25922, the minimal inhibitory concentration of which was 31.3 times (p < 0.0001) higher than that of staphylococci. The proposed citrate buffer-amoxiclav combination significantly increased the antimicrobial efficacy of its components against all the reference strains of microorganisms. Thus, the sensitivity of E. coli ATCC 25922 and M. lysodeikticus ATCC 4698 to the proposed combination increased 8-fold (p < 0.05) compared to their sensitivity to citrate buffer or amoxiclav alone. The sensitivity of Staphylococcus aureus and enterococcі to the composition increased to the maximum: up to 32-fold (p < 0.001) to the buffer and 4‑fold to the antibiotic (p < 0.01). The effect of a significant increase in the sensitivity of C. albicans ATCC10231 strain to the citrate buffer after adding amoxiclav was gone up 128-fold (p < 0.0001). It was the evidence of a synergistic fungicidal action of the antibiotic-citrate buffer combination.

Author Biographies

Olga V. Gancho, Microbiology, Virology and Immunology Department, Poltava State Medical University, Poltava, Ukraine

Candidate of Biological Sciences, Associate Professor of the Microbiology, Virology and Immunology Department of the Poltava State Medical University, Poltava, Ukraine

Phone: 0999647095, e-mail: o_gancho@ukr.net

Scopus-Author ID 57190737450

Tetiana D. Bublii, Therapeutic Dentistry Department, Poltava State Medical University, Poltava, Ukraine

Candidate of Medical Sciences, Associate Professor of Therapeutic Dentistry Department of the Poltava State Medical University, Poltava, Ukraine

Phone: 0509732519, e-mail: tbublii@gmail.com

Oleksij P. Kostyrenko, Therapeutic Dentistry Department, Poltava State Medical University, Poltava, Ukraine

Candidate of Medical Sciences, Associate Professor of Therapeutic Dentistry Department of the Poltava State Medical University, Poltava, Ukraine

Phone: 0976439451, e-mail: kostyrenko.oleksij@gmail.com

Scopus-Author ID 57222279020

Vira I. Fedorchenko , Microbiology, Virology and Immunology Department, Poltava State Medical University, Poltava, Ukraine

Candidate of Biological Sciences, Associate Professor of the Microbiology, Virology and Immunology Department of the Poltava State Medical University, Poltava, Ukraine,

Phone: 066 507 07 59, e-mail: fedorchenko.vira@gmail.com

Scopus-Author ID 57018868700

References

1. Barbosa-Ribeiro M, Arruda-Vasconcelos R, Mendes Louzada L, Rodrigues Lima A, Marciano M, Affonso de Almeida JF, De-Jesus-Soares A, Zaia AA, Ferraz C, Gomes BP. Microbiological Investigation in Teeth with Persistent/Secondary Endodontic Infection in Different Stages of Root Canal Retreatment. Eur Endod J. 2020 Dec;5(3):219-225.
2. Neetu J, Shalini G, Harjoy K. Impact of 6% citric acid and endoactivator as irrigation adjuncts on obturation quality and pulpectomy outcome in primary teeth. Pediatric Dental Journal.18 2019 June;24(2): 9-15.
3. Machado R, Garcia LDFR, da Silva Neto UX, Cruz Filho AMD, Silva RG, Vansan LP. 17% EDTA and 10% citric acid were evaluated in smear layer removal and tubular dentin sealer penetration. Microsc Res Tech. 2018 Mar;81(3):275-282.
4. Amaral RR, Braga T, Siqueira JF Jr, Rôças IN, CTC da Costa Rachid, Root Canal Microbiome Associated with Asymptomatic Apical Periodontitis as Determined by High-Throughput Sequencing. Journal of Endodontics. 2022 January;41(4):231-241.
5. Siqueira, JF. Endodontic infections: Concepts, paradigms, and perspectives. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2002, 94: 281–293.
6. Tennert C, Fuhrmann M, Wittmer A, Karygianni L, Altenburger MJ, Pelz, K. New bacterial composition in primary and persistent/secondary endodontic infections concerning clinical and radiographic findings. Journal of Endodontics. 2014, 40: 670–677.
7. Pourhajibagher M, Ghorbanzadeh R, Bahador A. Culture-dependent approaches to explore the prevalence of root canal pathogens from endodontic infections. Brazilian Oral Research 2017, 31:108.
8. Siqueira, JF, Sen BH Fungi in endodontic infections. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2004, 97: 632–641.
9. Saeed Rahimia Maryam Janani, Mehrdad Lotfi,c Shahriar Shahi,a Amirala Aghbali,a Mahdi Vahid Pakdel,d Amin Salem Milani,a and Negin Ghasemib. A Review of Antibacterial Agents in Endodontic Treatment. Iran Endod J. 2014 Summer; 9(3): 161–168.
10. Bublij TD, Gancho OV, Kosty`renko OP. [Antiseptic properties of citrate buffer]. Aktual`ni problemy` suchasnoyi medytsyny: Visnyk UMSA. 2021, 1(73):85-88. (Ukrainian).
11. Bublii TD, Kostyrenko OP, Parfonova VS, Higher State Educational Institution “Ukrainian Medical Stomatological Academy”, assignee. Method for impregnating dentin of the root canal of the tooth. Patent Ukraine patent 107843. 2016 June 24. (Ukrainian).
12. Farhada A, Saatchia M, Bagherieha Sh. An animal study is the effect of citric acid versus ethylenediaminetetraacetic acid on radiographic root development in regenerative endodontic treatment. Journal of Endodontics 2022 January; (53):184-189.
13. European Committee on Antimicrobial Susceptibility Testing. European antimicrobial breakpoints. Basel: EUCAST, 2021. Available from: https://eucast.org/clinical_breakpoints/
14. CLSI. ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems.2021. Available from: https://clsi.org/standards/products/iso-documents/documents/iso16256-ed2e/
Published
2022-03-29
How to Cite
Olga V. Gancho, Tetiana D. Bublii, Oleksij P. Kostyrenko, & Vira I. Fedorchenko. (2022). ANTIMICROBIAL EFFECT OF CITRATE BUFFER WITH ANTIBIOTIC. Eastern Ukrainian Medical Journal, 10(1), 80-87. https://doi.org/10.21272/eumj.2022;10(1):80-87